ID   KUR-20
AC   CVCL_WK64
SY   Kurume University Renal-20
DR   Wikidata; Q95980496
RX   PubMed=7671230;
RX   PubMed=9023415;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:11 (PubMed=7671230).
CC   HLA typing: A*02:01,02:10 (PubMed=9023415).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=7671230;
RA   Nakao M., Yamana H., Imai Y., Toh Y., Toh U., Kimura A., Yanoma S.,
RA   Kakegawa T., Itoh K.;
RT   "HLA A2601-restricted CTLs recognize a peptide antigen expressed on
RT   squamous cell carcinoma.";
RL   Cancer Res. 55:4248-4252(1995).
//
RX   PubMed=9023415; DOI=10.1006/cimm.1996.1062;
RA   Seki N., Hoshino T., Kikuchi M., Hayashi A., Itoh K.;
RT   "HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating
RT   lymphocytes of patients with non-small cell lung cancer.";
RL   Cell. Immunol. 175:101-110(1997).
//